Chong Kun Dang Pharmaceutical : Changesof 30% or More in Salesor Profits/Losses(15% or More in the Case of Large-sized Corporations)

Report of Disclosure Revision

Revision Date

2022-03-10

1. Disclosure Documents in relation with Revision	30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations)
2. Submission date of documents	2022-02-10
3. Reason for Revision	Correction due to changes in the financial statements since the last disclosure date (2022-02-10)
4. Revised Information
information	before revision	after revision
2.Detail of changes (KRW thou.) Operating income - Current fiscal Year - Amount increased/ decreased - Increase/ decrease rate (%) Net income from continuing operation before income tax - Current fiscal Year - Amount increased/ decreased - Increase/ decrease rate (%) Net income - Current fiscal Year - Amount increased/ decreased - Increase/ decrease rate (%)	96,686,594 -27,249,285 -22.0 82,521,754 -39,317,203 -32.3 43,817,821 -46,587,068 -51.5	94,758,694 -29,177,185 -23.5 80,593,854 -41,245,103 -33.9 42,356,472 -48,048,417 -53.1
3. Financial status (KRW thou.) - Total assets - Total liabilities - Total shareholders' equity - Total shareholders' equity/capital stock ratio (%)	1,046,233,520 478,962,529 567,270,992 1,985.9	1,046,700,072 480,890,429 565,809,643 1,980.8
[Matters Related to the Controlling Company] - Total shareholders' equity (excluding non-controlling shareholders' equity) - Total shareholders' equity/capital stock ratio(%) (excluding non-controlling shareholders' equity)	567,471,333 1,986.6	566,009,985 1981.5

- The financial statements above have not been audited by an external auditor, and are subject to change depending on the audit results.

Changes of 30% or More in Sales or Profits/Losses (15% or More in the Case of Large-sized Corporations)

※ Note that this disclosure is stated by the concerned company, thus the details may be changed according to audit results. Refer to the disclosure "Submission of Audit Report" for finalized details.
1. Type of financial statements	Consolidated financial statements
2. Details of changes (KRW thou.)	Current fiscal year	Previous fiscal year	Amount increased/ decreased	Increase/ decrease rate (%)
- Sales (limited to amount of revenue according to sales of goods and services provided)	1,343,559,363	1,303,005,524	40,553,839	3.1
- Operating income	94,758,694	123,935,879	-29,177,185	-23.5
- Net income from continuing operation before income tax	80,593,854	121,838,957	-41,245,103	-33.9
- Net income	42,356,472	90,404,889	-48,048,417	-53.1
- Classified as a large-sized corporation?	No
3. Financial status (KRW thou.)	Current fiscal year	Previous fiscal year
- Total assets	1,046,700,072	946,333,120
- Total liabilities	480,890,429	394,740,342
- Total shareholders' equity	565,809,643	551,592,778
- Capital stock	28,565,248	27,214,213
- Total shareholders' equity/capital stock ratio (%)	1,980.8	2,026.9
4. Main causes for changes in sales or profits/losses amount	Reduction in net income following one-time costs and increased R&D costs.
5. Date of board resolution (decision date)	2022-02-10
- Attendance of outside directors	Present (No.)	2
Absent (No.)	0
- Attendance of auditors (members of Audit Committee who are not outside directors)	Present
6. Other matters to be factored into investment decisions
- The materials for the current fiscal year above are based on the consolidated financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS). - The data above have not been audited by an external auditor, and as such, they are subject to change in the future.
※ Related disclosure	-

[Matters Related to Parent Company]

Category	Financial statements	Current fiscal year	Previous fiscal year
Total shareholders' equity (excluding non-controlling shareholders' equity)	Consolidated financial statements	566,009,985	551,426,758
Total shareholders' equity/capital stock ratio(%) (excluding non-controlling shareholders' equity)	Consolidated financial statements	1,981.5	2,026.2
Sales amount (limited to amount of revenue according to sales of goods and services provided) (KRW thou.)	Non-consolidated financial statements	1,333,988,910	1,300,544,358